Table 2.
A summary of markers expressed by cells observed in or derived from various sources which have the potential to develop into hepatocytes
| From bone marrow (haematopoietic stem cells) |
| CD34+lin−(Theise) |
| Sca-1+Thy-1+CD34+lin−CD45+(Lagasse) |
| β2micro−Thy-1+Thy-1+Alb+AFP+CK8+CK18+CK19+C/EBPa+CYP3A2+HNF4+CD34−CD38−CD117−(Avital) |
| CD34+Thy-1+CD117+AFP+c-met+(Oh and Miyazaki) |
| Sca-1+Thy-1+(Okumota) |
| CXCR-4+AFP+Sca-1+c-met+CK19+(Ratajczak) |
| CD34+/–CD45+CD38−lin−C1rRp+ (Danet) |
| CD34+CD38−CD7− (Wang and Ge) |
| β2micro−Thy-1+C/EBP+Alb+ (Avital) |
| CD34+CD45+ (Fiegel) |
| CD34+CD133+AFP+CXCR-4+ (Ratajczak) |
| From bone marrow (mesenchymal stem cells) |
| CD45−glycophorin-A− (Schwartz) (Schwartz) (Jiang) |
| Str1+CD13+CD49a+ CD49b+CD29+CD44+CD71+Thy-1+CD106+CD124+ |
| CD34−CD44−CD45−CD117−MHC−β2microlowCD133lowFlklowFltlowCD13+CD49b+ |
| From peripheral blood |
| AFP+CK19+(Ratajczak) (Ratajczak) |
| CD14+ (Zhao) |
| From cord blood |
| CD34+/–CD45+CD38−lin−C1rRp+ (Danet) |
| CD34+CD38−CD7− (Wang and Ge) |
| CD34+/– (Kakinuma) |
| CD34+ or CD45+ (Ishikawa) |
| From foetal liver |
| AFP+Alb+GGT+AAT+glutathione-S-transferase+ |
| MHC class-I−ICAM-1+(Kubota and Reid) |
| OX43−OX44−(Fiegel) |
| CD45−TER119−CD49f+/lowCD29+CD117−c-met+(Suzuki) |
| CD117lowCD45−TER119−CD49f+/–alb+AFP+TTR+HGF+OSMR+ c-met+(Minguet) |
| DLK+Alb+AFP+CK19+(Tanimizu) |
| Alb+AFP+CK19+CD49f+Thy-1−CD45−(Yasuchika) |
| HepPar1+CK19+CK14+ (Haruna) |
| β1 and α1,5,6,9 integrin+ (Couvelard) |
| AFP+GGT+CK8+CK19+CD34+plasminogen activator inhibitor 1+ (Malhi) |
| From adult liver (Oval cells) |
| CK19+GGT+AFP+Thy-1+CD117+CD34+SCF+OV6+OC.2+BD1+CD45–/+Sca-1+A6+ |
| CXCR4+(Hatch) |
| β2micro−Thy-1+(Avital) |
| AFP+CD45−TER119−CD117−Thy-1−CD49f+CD29+(Fujikawa) |
| Alb+transferrin+CK8+CK18+(Mitaka) |
| OC.2+OC.5+CD34−Thy-1−AFP+CYP450−(Gordon) |
| SP+CD45+/– and minority CD34+CD117+Sca-1+Thy-1+(Wulf) |
| CK19+CD117+ (Theise) |
| CD117+ and/or CD34+ (Crosby) |
| OV6+ (Crosby) |
| CK14+CD117+CD34−Alb− (Seki) |
| From embryonic stem cells |
| SSEA-1+SSEA-3−SSEA-4− (Henderson) |
| SSEA-1−SSEA-3+SSEA-4+Tra-1-60+Tra-1-81+Thy-1+ (Henderson) |
| Oct-4+ (Nichols) (Reubinoff) |
| SSEA-1−SSEA-3+SSEA-4+Tra-1-60+Tra-1-81+Oct4+hTERT+CD133+ (Carpenter) |
Rodent studies are in italic and human studies are in normal text.